Cambridge Investment Research Advisors’s Immunomedics Inc IMMU Stock Holding History

Cambridge Investment Research Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,634	Closed	-$394K	–	2815
2020 Q3	$394K	Buy	+4,634	New	+$234K	﹤0.01%	1758
2016 Q3	–	Sell	-10,800	Closed	-$25K	–	1804
2016 Q2	$25K	Buy	+10,800	New	+$36.1K	﹤0.01%	1534
2015 Q3	–	Sell	-15,800	Closed	-$64K	–	1615
2015 Q2	$64K	Buy	+15,800	New	+$64.6K	﹤0.01%	1398

Cambridge Investment Research Advisors's IMMU Position: Q4 2020 in Review

Cambridge Investment Research Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,634 shares — an estimated $394K sold.

Cambridge Investment Research Advisors first reported a position in IMMU in Q2 2015 and held it in 3 quarters. The position peaked at $394K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Cambridge Investment Research Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Cambridge Investment Research Advisors sold 4,634 Immunomedics Inc shares in Q4 2020, an estimated $394K.
Cambridge Investment Research Advisors first reported a position in Immunomedics Inc in Q2 2015 and held it in 3 quarters.
Cambridge Investment Research Advisors's Immunomedics Inc position peaked at $394K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.